96 Participants Needed

Saline Flush for Empyema

(RELIEF Trial)

Recruiting at 2 trial locations
SS
JD
Overseen ByJennifer Duke, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt University Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Infections of the pleural space are common, and patients require antibiotics and chest drain placement to evacuate the chest from the infected fluid. Chest drains can get blocked by the drainage fluid and material. For this reason, it is thought that flushing the chest drain with saline solution, can help maintain the patency of the tube. This proposed study will evaluate the impact of regular chest drain flushing on the length of time to chest tube removal and total hospitalization as well as improvement in chest imaging and the need for additional interventions on the infected space.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

What data supports the effectiveness of the treatment Saline Flush for empyema?

Research shows that using saline flushes in combination with other treatments like urokinase can be effective for managing empyema, a condition where pus collects in the space around the lungs. Saline flushes alone have been used in studies to help treat empyema, suggesting they may help in clearing the infection.12345

Is saline flush generally safe for humans?

Saline flushes are generally safe for humans, but some people may experience taste and odor disturbances when using prefilled syringes due to substances from the plastic. There are no major safety concerns reported in the studies reviewed.678910

How does saline flush treatment for empyema differ from other treatments?

Saline flush treatment for empyema is unique because it uses a simple saltwater solution to help clear the infection, which is different from more complex treatments that might involve antibiotics or surgical interventions. This approach is less invasive and focuses on using the body's natural processes to aid recovery.911121314

Research Team

JD

Jennifer D Duke, MD

Principal Investigator

Vanderbilt University

Eligibility Criteria

This trial is for patients with infections in the space around their lungs, requiring chest drains. Participants must need antibiotics and a chest drain due to infected fluid. The study excludes individuals if specific criteria that could interfere with the trial's process or outcomes are met.

Inclusion Criteria

I am older than 18 years.
I have a severe lung infection requiring a chest tube as part of my treatment.

Exclusion Criteria

Patients who have surgical tubes that can't accommodate a three-way stopcock
Inability to provide informed consent
Inability to undergo a chest X-ray
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive regular saline flushes into their chest drain every 6 hours or as needed to maintain patency

up to 3 months

Follow-up

Participants are monitored for safety and effectiveness after treatment, including additional surgical procedures and time to chest tube removal

3 months

Treatment Details

Interventions

  • Saline Flush
Trial OverviewThe study tests whether flushing the chest drain with saline solution helps keep it clear, potentially reducing how long it stays in and overall hospital stay. It also looks at improvements in lung imaging and if fewer follow-up procedures are needed.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Saline Intervention ArmExperimental Treatment1 Intervention
Patient will receive 20 mL sterile saline flushes into their catheter by study team members every 6 ± 2 hours. If patients are receiving intrapleural tissue plasminogen activator and deoxyribonuclease therapy, each treatment will be considered one flush.
Group II: No Intervention ArmActive Control1 Intervention
Patient will receive a saline flush as needed, to restore patency of a chest tube considered blocked. No routine flushes will be administered.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt University Medical Center

Lead Sponsor

Trials
922
Recruited
939,000+

Findings from Research

In a study of 9 patients with post-surgical thoracic empyema, antibiotics amoxicillin and vancomycin showed good diffusion into the pleural cavity, with pleural concentrations often higher than those in the plasma.
The treatment was effective, with 8 out of 9 patients experiencing a cure of their pleural infection, indicating that these antibiotics can be effective in managing post-surgical empyema.
[Pleural diffusion of amoxicillin 1 and vancomycin in patients treated for post-surgical empyema].Stern, JB., Péan, Y., Girard, P., et al.[2019]
In a study of 62 patients with complicated parapneumonic effusions or empyemas, adding manual pleural saline flushing to urokinase treatment significantly reduced the need for multiple doses of fibrinolytics, with only 15% requiring more than one dose compared to 44% in the urokinase-only group.
Patients receiving saline flushing also experienced shorter chest tube duration (2 days vs. 5 days) and reduced hospital stays (6 days vs. 8 days), with no reported adverse events from the saline therapy, indicating it is a safe and effective adjunct treatment.
Manual Intrapleural Saline Flushing Plus Urokinase: A Potentially Useful Therapy for Complicated Parapneumonic Effusions and Empyemas.Porcel, JM., Valencia, H., Bielsa, S.[2019]
In a study of 42 patients with pleural empyema, serial thoracocentesis combined with saline irrigation was highly effective for treating empyema resulting from pneumonia, achieving an 86% success rate without needing more invasive procedures.
The treatment was less effective for empyema caused by other factors, with only a 69% success rate and a significant crossover to more invasive therapies, indicating that different approaches may be necessary for non-pneumonic cases.
Minimally invasive treatment of thoracic empyema.Simmers, TA., Jie, C., Sie, B.[2014]

References

[Pleural diffusion of amoxicillin 1 and vancomycin in patients treated for post-surgical empyema]. [2019]
Manual Intrapleural Saline Flushing Plus Urokinase: A Potentially Useful Therapy for Complicated Parapneumonic Effusions and Empyemas. [2019]
Minimally invasive treatment of thoracic empyema. [2014]
Intrapleural streptokinase for empyema and complicated parapneumonic effusions. [2022]
Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. [2008]
Using a Saline Flush "Site Unseen" Could Lead to a Wrong-Route Error. [2020]
Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. [2015]
Taste and Odour Disturbances in Pediatric Patients Undergoing IV Flush with Normal Saline Administered by Prefilled or Freshly Prepared Syringes: Randomized Single-Blind Study. [2019]
Efficacy of normal saline in the maintenance of the arterial lines in comparison to heparin flush: a comprehensive review of the literature. [2017]
10.United Statespubmed.ncbi.nlm.nih.gov
Safety of a preservative-free acidified saline nasal spray: a randomized, double-blind, placebo-controlled, crossover clinical trial. [2015]
[Postoperative inhalation treatment after paranasal sinus interventions. A placebo-controlled, double-blind and randomized study]. [2015]
Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Heparin versus saline flushing solutions in a small community hospital. [2022]
[Effectiveness and tolerance of nasal irrigation following paranasal sinus surgery]. [2015]